• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur Heart J Suppl . The impact of influenza vaccination on cardiovascular diseases

tetano

Editor, Senior Moderator
Eur Heart J Suppl


. 2023 Feb 14;25(Suppl A):A25-A30.
doi: 10.1093/eurheartjsupp/suac126. eCollection 2023 Feb.
The impact of influenza vaccination on cardiovascular diseases


Amelia Carro[SUP] 1 [/SUP]



Affiliations
Free PMC article

Abstract

The link between influenza and medical complications is well stablished and plays a role in the high mortality rates of this disease. Available scientific evidence suggests that influenza vaccination might reduce the risk of cardiovascular events. This setting for cardiovascular prevention beyond immunoprotection has been studied in several clinical trials. Most of them include populations with coronary artery disease. However, differences in clinical design, population included, and vaccination strategies might explain divergent results and should be interpreted with caution. The present article summarizes available literature in a manner that aids physicians in a better interpretation and encourages the implementation of influenza vaccination in cardiovascular prevention programmes.

Keywords: Cardiovascular disease; Cardiovascular prevention; Heart failure; Influenza; Influenza vaccination; Myocardial infarction.
 
Back
Top Bottom